Table 1.
Patient Characteristics
| Variables | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 |
|---|---|---|---|---|---|---|
| Age, years | 76 | 74 | 79 | 30 | 74 | 75 |
| Sex | Male | Male | Male | Female | Male | Female |
| HF etiology | ICM | NICM | NICM | Congenital | NICM | NICM |
| CAD | Y | N | N | N | Y | N |
| HTN | Y | Y | N | N | Y | Y |
| DM | Y | N | Y | N | N | N |
| Stroke | N | N | N | N | N | N |
| Type of LVAD | HMII | HVAD | HM3 | HM3 | HMII | HM3 |
| Intent of therapy | DT | DT | DT | BTD | DT | DT |
| Time post-LVAD, months | 64.8 | 81.6 | 10.8 | 0.03 | 70.8 | 12 |
| Laboratory parameters | ||||||
| WBC, /μL | 3.8 | 6.3 | 4/9 | 20/3 | N/A | 4.83 |
| ALC (initial) | 270 | 500 | 600 | 1200 | N/A | 1030 |
| ALC (trough) | 240 | 500 | 300 | 500 | N/A | 1030 |
| CRP (initial), mg/L | 162 | 61 | 46 | 163 | N/A | 0.5 |
| CRP (peak), mg/L | 163.5 | 161.5 | 100 | 167 | N/A | N/A |
| IL-6, pg/L | N/A | 6 | N/A | 97 | N/A | N/A |
| Ferritin. ng/mL | 370.1 | 688.2 | 1623 | 1366 | N/A | 59.1 |
| d-Dimer, μg/mL | 0.8 | 1.3 | 2.4 | 10.4 | N/A | 651 |
| Troponin T, ng/dL | 26 | 96 | N/A | N/A | N/A | N/A |
| Troponin I, ng/dL | N/A | N/A | 0.3 | 1.2 | N/A | N/A |
| Time of follow-up after COVID diagnosis | 5 days | 5 months | 4.5 months | 12 days | 4.5 months | 1.5 months |
| Status at last follow-up | Deceased | Recovered | Recovered | Deceased | Recovered | Recovered |
ALC, absolute lymphocele count; BTD, bridge to decision; CAD, coronary artery disease; CRP, C-reactive protein; DM, diabetes; DT, destination therapy; HF, heart failure; HM, Heartmate; HTN, hypertension; HVAD, HeartWare; ICM, ischemic cardiomyopathy; N/A, not available; NICM, nonischemic cardiomyopathy; WBC, white blood cell count.